Remove Compliance Remove Fractional CTO Remove Pharmaceuticals Remove Technical Review
article thumbnail

Weighing risk and reward with gen AI vendor selection

CIO

Putting aside the fact this is an astronomically high adoption rate for a brand new technology, it’s also an indicator of how risky this space is. When assessing vendors, Rich Products looks at their technology, architecture, business value, and pragmatic perspective. A startup can easily become obsolete in any area of technology.

article thumbnail

How generative AI impacts your digital transformation priorities

CIO

But with all the excitement and hype, it’s easy for employees to invest time in AI tools that compromise confidential data or for managers to select shadow AI tools that haven’t been through security, data governance, and other vendor compliance reviews.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

10 Ways Machine Learning and AI Revolutionizes Medicine and Pharma

Altexsoft

In fact, they estimate the technology could generate up to $100B in value annually. Drug manufacturers actively collaborate with tech companies, researchers, startups and more, thus sharing the data of millions of people. Stanford is actively using the technology to identify the different types of skin cancer. Health outcomes.

article thumbnail

22 Health IT Experts Reveal the Single Best Way to Simplify Interoperability in Healthcare IT

Datica

There is no shortage of technology platforms available in this industry, but unfortunately there’s a huge disconnect between them with many of these systems having been built in silos. The best road to interoperability in healthcare available to us today is to demand an open architecture from vendors and technology providers.